Evidence map›Paper›PMID 35424874›Full record

ReviewRSC advances2022

Molecularly imprinted polymers

Irvin Veloz Martínez, Jackeline Iturbe Ek, Ethan C Ahn, Alan O Sustaita

Abstract readReview
In one paragraph

Review in RSC advances, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Irvin Veloz MartínezSchool of Engineering and Science, Tecnologico de Monterrey Av. Eugenio Garza Sada 2501 Monterrey N.L. 64849 Mexico alan.sustaita@tec.mx.ORCID https://orcid.org/0000-0001-6402-4595
Jackeline Iturbe EkSchool of Engineering and Science, Tecnologico de Monterrey Av. Eugenio Garza Sada 2501 Monterrey N.L. 64849 Mexico alan.sustaita@tec.mx.ORCID https://orcid.org/0000-0001-5495-182X
Ethan C AhnDepartment of Electrical and Computer Engineering, The University of Texas at San Antonio San Antonio TX 78249 USA.ORCID https://orcid.org/0000-0002-0807-2071
Alan O SustaitaSchool of Engineering and Science, Tecnologico de Monterrey Av. Eugenio Garza Sada 2501 Monterrey N.L. 64849 Mexico alan.sustaita@tec.mx.ORCID https://orcid.org/0000-0002-2039-2166

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Molecularly imprinted polymers (MIP) have shown their potential as artificial and selective receptors for environmental monitoring. These materials can be tailor-made to achieve a specific binding event with a template through a chosen mechanism. They are capable of emulating the recognition capacity of biological receptors with superior stability and versatility of integration in sensing platforms. Commonly, these polymers are produced by traditional free radical bulk polymerization (FRP) which may not be the most suitable for enhancing the intended properties due to the poor imprinting performance. To improve the imprinting technique and the polymer capabilities, controlled/living radical polymerization (CRP) has been used to overcome the main drawbacks of FRP. Combining CRP techniques such as RAFT (reversible addition-fragmentation chain transfer) with MIP has achieved higher selectivity, sensitivity, and sorption capacity of these polymers when implemented as the transductor element in sensors. The present work focuses on RAFT-MIP design and synthesis strategies to enhance the binding affinities and their implementation in environmental contaminant sensing applications.

Identifiers

PMID35424874
PMCPMC8985154

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.